Morphological Changes Depending on the Contentof Clozapine and its Metabolites in the Lungs and Serum (Experimental Study)

The purpose of the study: to assess the morphological changes in the lungs depending on the content of clozapine and its metabolites in the lungs and serum.

Materials and methods. The experiments were performed on male outbred rats weighing 290-350 g at the age of 20 weeks (n=15). The animals were divided into 3 groups: Group 1 — reference group (intact rats) (n=5); Group 2 -poisoning with clozapine (n=5); Group 3 — poisoning with a combination of clozapine with ethanol (n=5). Clozapine was administered orally at a dose of 150 mg per kg of animal's body weight under general anesthesia; alcohol was administered together with clozapine orally at a dose of 5 ml per kg of animal's body weight. Further study was carried out 24 hours after administration of drugs to animals of the 2nd and 3rd groups. After euthanasia of the animals by decapitation, tissue samples of lungs were embedded in paraffin according to the standard technique. Then 5-μm thick histological sections were made and examined using light microscopy with the aid of a Nikon Eclipse E400 microscope equipped with a video system based on the Watec 221S camera (Japan) at magnification of X200 and X400. The following pathological patterns were assessed: disorder of blood circulation (hyperemia, hemorrhage, and sludge), the presence of atelectasis and dystelectasis, the presence of emphysema, the cellular response (an increase in the white blood cell count), and desquamation of epithelium into the lumen of the bronchi. A chemical and toxicological study was performed on a high-performance liquid chromatograph with mass detector Agilent Technologies 430 Triple Quad LC/MS (Germany). To obtain chromatograms, the following software was used: Agilent Mass Hunter Workstation for series tripple Quadrapole vers. B06.00 build 6.0.6.25.4sp4.

The following software was used for processing chromatograms: Agilent Mass Hunter Quantitive Analysis vers. B 07.00 build 7.0.457.0. Serum and lung homogenate levels of clozapine, norclozapine, and clozapine-N — oxide were evaluated.

Results. In 24 hours, animals in the 2nd group exhibited atelectasis and dystelectasis in the lung tissue, and leukocyte infiltration; in the 3rd group, arterial hyperemia, cellular response (an increase in the white blood cell count), atelectasis and dystelectasis, and thickening of interalveolar septa were revealed. In 24 hours, in the lungs of animals of the 3rd group, the concentration of clozapine increased by 22.2-fold, norclozapine by 6.6-fold, and clozapine-Noxide by 6.2-fold as compared to the 2nd group; in serum it increased by 5.7-, 2.0and 4.6-fold, respectively.

Conclusion. In the case of poisoning with clozapine in combination with ethanol, a complex of pathological changes in the lungs develops, which is more severe than the isolated effect of clozapine administered as a single drug. The concentration of clozapine and its metabolites in the lung tissue and blood serum is higher when it enters the body in combination with ethanol.

1. Stopnitsky A.A., Akalaev R.N. Intensive therapy of patients with acetic acid poisoning complicated by shock. Obshchaya Reanimatologiya = General Reanimatology. 2014; 10 (2): 18-22. DOI: 10.15360/1813-97792013-2-18. [In Russ., In Engl.]

2. Schulz M., Iwersen-Bergmann S., Andresen H., Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit. Care. 2012; 16 (4): R136. DOI: 10.1186/cc11441. PMID: 22835221

3. Mashkovsky M.D. Medicinal products. 16-th ed. Moscow: Novaya Volna; 2012: 73-74. ISВN 978-5-7864-0218-7. [In Russ.]

4. Slyundin D.G., Livanov A.S., Anuchin V.V., Bobrinskaya I.G., Tutova E.V. Criminal clozapine intoxications. Anesteziologiya i Reanimatologiya. 2007; 4: 61-64. PMID: 17929492. [In Russ.]

5. VIDAL directory. Medicines in Russia. 21-st ed. Moscow: AstraFarmServis; 2012: 8. ISBN: 978-5-89892-165-1. [In Russ.]

6. Subramanian S., Völlm B.A., Huband N. Clozapine dose for schizophrenia. Cochrane Database Syst. Rev. 2017; 6: CD009555. DOI: 10.1002/14651858.CD009555.pub2. PMID: 28613395

7. Barsegyan S.S., Nikolaeva N.O., Onishchenko M.M., Salomatin E.M., Salnikova E.A. The determination of clozapine for the forensic chemical study of cadaveric blood, urine, and liver with the use of high performance liquid chromatography. Sudebno-Meditsinskaya Ekspertiza. 2012; 55 (4): 43-47. PMID: 23008960. [In Russ.]

8. Romanova O.L., Stepanova E.S., Barsegyan S.S., Sundukov D.V., Chistyakov V.V. Simultaneous determination of clozapine, norclozapine, clozapine-noxide in serum and organs. Farmatsiya. 2016; 65 (5): 27-29. [In Russ.]

9. Romanova O.L., Sundukov D.V., Golubev A.M., Babkina A.S., Golubev M.A. Morphological changes in the heart with clozapine poisoning (experimental study). Obshchaya Reanimatologiya = General Reanimatology. 2017; 13 (2): 6-13. DOI: 10.15360/1813-9779-2017-2-6-13. [In Russ., In Engl.]

10. Golubev A.M., Moroz V.V., Meshcheryakov G.N., Lysenko D.V. Acute pulmonary lesion: pathogenesis and morphology. Obshchaya Reanimatologiya = General Reanimatology. 2005; 1 (5): 5-12. DOI: 10.15360/1813-9779-2005-5-5-12. [In Russ., In Engl.]

11. Ilyashenko K.K., Luzhnikov E.A., Belova M.V., Ermokhina T.V., Lisovik Zh.A., Kareva M.V., Elkov A.N., Zimina L.N., Barinova M.V. Features of acute poisonings by klozapin. Toksikologichesky Vestnik. 2009; 2: 2-5. [In Russ.]

12. Michard F., Fernandez-Mondejar E., Kirov M.Y., Malbrain M., Tagami T. A new and simple definition for acute lung injury. Crit. Care Med. 2012; 40 (3): 1004-1006. DOI: 10.1097/CCM.0b013e31823b97fd. PMID: 22343856

13. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., Lamy M., Legall J.R., Morris A., Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994; 149 (3 Pt 1): 818-824. DOI: 10.1164/ajrccm.149.3.7509706. PMID: 7509706

14. Romanova O.L., Sundukov D.V., Golubev A.M., Blagonravov M.L., Golubev M.A. Characteristics of general pathological processes in the lungs following clozapine poisoning. Obshchaya Reanimatologiya = General Reanimatology. 2017; 13 (4): 22-29. DOI: 10.15360/1813-9779-20174-22-29. [In Russ., In Engl.]

15. Ziliene V., Kondrotas A.J., Kevelaitis E. Etiology and pathogenesis of acute respiratory failure. Medicina (Kaunas). 2004; 40 (3): 286-294. PMID: 15064552

16. Kuzovlev A.N., Moroz V.V., Goloubev A.M., Polovnikov S.G. Diagnosis of acute respiratory distress syndrome in nosocomial pneumonia. Semin. Cardiothorac. Vasc. Anesth. 2010; 14 (4): 231-241. DOI: 10.1177/1089253210388297. PMID: 21193470

17. Glushkov S.I., Kutsenko S.A., Karpishchenko A.I., Novikova T.M. The state of the glutathione system and processes of lipid peroxidation in red blood cells of patients with acute poisonings with sedative-hypnotic substances. Toksikologichesky Vestnik. 2003; 5: 6-12. [In Russ.]

18. Bogomolova I.N., Bogomolov D.V. Thanatogenesis in poisoning with psychic drugs. Sudebno-Meditsinskaya Ekspertiza. 2005; 48 (2): 19-22. PMID: 15881137. [In Russ.]

19. Chernyaev A.L., Samsonova M.V. General and special pathology of the lung. Respiratornaya Meditsina. Moscow: GEOTAR Media; 2007: 131-155. [In Russ.]

20. Marino P.L. Intensive care. Moscow: GEOTAR-Media; 2010: 770. ISBN 978-5-9704-1399-9. [In Russ.]

21. Moroz V., Goloubev A., Kuzovlev A.N. Acute respiratory distress syndrome: new classification. Semin. Cardiothorac. Vasc. Anesth. 2010; 14 (1): 46. DOI: 10.1177/1089253210364249. PMID: 20472624

22. Golubev A.M., Moroz V.V., Sundukov D.V. Pathogenesis of acute respiratory distress syndrome. Obshchaya Reanimatologiya = General Reanimatology. 2012; 8 (4): 13-21. DOI:10.15360/1813-9779-2012-4-13. [In Russ., In Engl.]

23. Cook J.A., Gesel J., Haluska P.V., Reines H.D. Prostaglandins, tromboxanes, leukotrienes and cytochrome P-450 metabolites of arachidonic acid. New Horiz. 1993; 1 (1): 60-69. PMID: 7922394

24. Yang G., Hamacher J., Gorshkov B., White R., Sridhar S., Verin A., Chakraborty T., Lucas R. The dual role of TNF in pulmonary edema. J. Cardiovasc. Dis. Res. 2010; 1 (1): 29-36. DOI: 10.4103/0975-3583.59983. PMID: 21188088

25. Hirani N., Antonicelli F., Strieter R.M., Wiesener M.S., Ratcliffe P.J., Haslett C., Donnelly S.C. The regulation of Interleukin-8 by hypoxia in human macrophages: a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol. Med. 2001; 7 (10): 685-689. PMID: 11713368

26. Hardaway R.M. Pathology and the physiology of disseminated intravascular coagulation. Pathophysiology of shock, anoxia, ischemia. Baltimore: Williams & Wilkins. 1982: 186-197.

27. Leaver S.K., Evans T.W. Acute respiratory distress syndrome. Br. Med. J. 2007; 335 (7616): 389-394. DOI: 10.1136/bmj.39293.624699.AD. PMID: 17717368